Phase III, randomised, double-blind, placebo-controlled trial of Neuroaspis plp10 as an adjuvant treatment for relapsing multiple sclerosis: the MINERAL Study
一项评估Neuroaspis plp10作为复发型多发性硬化症辅助治疗的III期随机、双盲、安慰剂对照试验：MINERAL研究
期刊:BMJ Neurology Open
影响因子:2.4
doi:10.1136/bmjno-2022-000334
Pantzaris, Marios C; Bakirtzis, Christos; Grigoriadis, Nikolaos; Hadjigeorgiou, Georgios; Dardiotis, Efthimos; Loucaides, George; Ntzani, Evangelia; Markozannes, Georgios; Omorfos, Savvas; Valsasina, Paola; Messina, Roberta; Preziosa, Paolo; Rocca, Maria A; Patrikios, Ioannis
